Madrigal Pharmaceuticals Inc banner

Wall St Price Targets

MDGL Price Forecast
Based on 21 analysts

+55% Upside
from $442.17 today

Madrigal Pharmaceuticals Inc (MDGL)’s 12-month stock price forecast through October 2027 has a consensus target of $683.4, implying 55% upside. The forecast is based on price targets from 21 Wall Street analysts.

MDGL Analyst Rating
Based on 19 analysts

avg. 4.74 of 5
Strong buy
15 79%
Buy
3 16%
Hold
1 5%
Sell
0 0%
Strong sell
0 0%

Analysts rate MDGL Strong buy, with 18 of 19 recommending Buy or Strong buy.

Madrigal Pharmaceuticals Inc Competitors:
Price Targets

Financial Estimates

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Value YoY Lowest–highest Analysts
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is MDGL's stock price target?
Price Target
683.4 USD

According to Wall Street analysts, the average 1-year price target for MDGL is 683.4 USD with a low forecast of 538.33 USD and a high forecast of 1 010.1 USD.

What is the Revenue forecast for Madrigal Pharmaceuticals Inc?
Projected CAGR
27%

Over the last 13 years, the compound annual growth rate for Revenue has been 102%. The projected CAGR for the next 8 years is 27%.

What is the Gross Profit forecast for Madrigal Pharmaceuticals Inc?
Projected CAGR
26%

The compound annual growth rate for Gross Profit over the next 8 years is 26%.

Back to Top